Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the NAD+ salvage pathway is upregulated in various cancers, including gastric 4, colon 5, pancreatic 6, and breast cancers 7. This evidence concerns the gene NAMPT and breast cancer.